Patent · US Active

Oxadiazole HDAC inhibitors

US8981084B2 · kind B2 · utility

12Cited by

3References

7Claims

0Family size

Assignee

Tempero Pharmaceuticals, Inc. · US

Inventors

Erkan Baloglu · Stoneham, US
Shomir Ghosh · Brookline, US
Mercedes Lobera · Concord, US
Darby Schmidt · Arlington, US

Key dates

Filing date	Jan 13, 2011
Grant date	Mar 17, 2015
Priority date	—
Expiry date	Feb 12, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds having the formula:wherein X1, X2, X3, R1, R2, Y, Q, X, B and L are as defined herein, and methods of making and using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.